170 related articles for article (PubMed ID: 34354085)
1. An annotated T2-weighted magnetic resonance image collection of testicular germ and non-germ cell tumors.
Feliciani G; Mellini L; Loi E; Piccinini F; Galeotti R; Sarnelli A; Parenti GC
Sci Data; 2021 Aug; 8(1):209. PubMed ID: 34354085
[TBL] [Abstract][Full Text] [Related]
2. The potential role of MR based radiomic biomarkers in the characterization of focal testicular lesions.
Feliciani G; Mellini L; Carnevale A; Sarnelli A; Menghi E; Piccinini F; Scarpi E; Loi E; Galeotti R; Giganti M; Parenti GC
Sci Rep; 2021 Feb; 11(1):3456. PubMed ID: 33568713
[TBL] [Abstract][Full Text] [Related]
3. Imaging Techniques to Differentiate Benign Testicular Masses from Germ Cell Tumors.
Saidian A; Bagrodia A
Curr Urol Rep; 2023 Sep; 24(9):451-454. PubMed ID: 37368095
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of testicular seminoma and nonseminomatous germ cell tumor on magnetic resonance imaging.
Liu R; Lei Z; Li A; Jiang Y; Ji J
Medicine (Baltimore); 2019 Nov; 98(45):e17937. PubMed ID: 31702681
[TBL] [Abstract][Full Text] [Related]
5. Testicular tumors: discriminative value of conventional MRI and diffusion weighted imaging.
Wang W; Sun Z; Chen Y; Zhao F; Yu H; Guo X; Shi K
Medicine (Baltimore); 2021 Dec; 100(48):e27799. PubMed ID: 35049179
[TBL] [Abstract][Full Text] [Related]
6. [An MRI study of primary testicular tumors].
Salamand P; Mianné D; Briant JF; Richez P
J Radiol; 1998 Sep; 79(9):865-70. PubMed ID: 9791766
[TBL] [Abstract][Full Text] [Related]
7. Significance of 18F-FDG PET/CT in Characterization of Equivocal Lesions in High-Risk Testicular Carcinoma in Restaging Setting.
Rasheed R; Al-Kandari F; Ghanem M; Marafi F; Usmani S
Asian Pac J Cancer Prev; 2020 Feb; 21(2):511-515. PubMed ID: 32102532
[TBL] [Abstract][Full Text] [Related]
8. Testicular epidermoid cysts: a reevaluation.
Anheuser P; Kranz J; Stolle E; Höflmayer D; Büscheck F; Mühlstädt S; Lock G; Dieckmann KP
BMC Urol; 2019 Jun; 19(1):52. PubMed ID: 31185974
[TBL] [Abstract][Full Text] [Related]
9. Incidence of testicular tumor subtypes according to the updated WHO classification, North Rhine-Westphalia, Germany, 2008-2013.
Stang A; Rusner C; Trabert B; Oosterhuis JW; McGlynn KA; Heidinger O
Andrology; 2019 Jul; 7(4):402-407. PubMed ID: 30578617
[TBL] [Abstract][Full Text] [Related]
10. Beyond germ cell tumors, unusual testicular and extra-testicular masses and mass-like lesions: MRI and US pictorial review.
AlGhamdi M; AlYami M; Faqeeh S; AlKubeyyer B; AlShabyli N; AlAyed A
Clin Imaging; 2021 Jun; 74():106-122. PubMed ID: 33485115
[TBL] [Abstract][Full Text] [Related]
11. MRI for evaluation of scrotal pathology.
Schultz-Lampel D; Bogaert G; Thüroff JW; Schlegel E; Cramer B
Urol Res; 1991; 19(5):289-92. PubMed ID: 1659016
[TBL] [Abstract][Full Text] [Related]
12. Characterization of testicular germ cell tumors: Whole-lesion histogram analysis of the apparent diffusion coefficient at 3T.
Min X; Feng Z; Wang L; Cai J; Yan X; Li B; Ke Z; Zhang P; You H
Eur J Radiol; 2018 Jan; 98():25-31. PubMed ID: 29279166
[TBL] [Abstract][Full Text] [Related]
13. Molecular Imaging for Evaluation of Viable Testicular Cancer Nodal Metastases.
Joice GA; Rowe SP; Gorin MA; Pierorazio PM
Curr Urol Rep; 2018 Nov; 19(12):110. PubMed ID: 30413968
[TBL] [Abstract][Full Text] [Related]
14. [Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors].
Müller-Mattheis V; Reinhardt M; Gerharz CD; Fürst G; Vosberg H; Müller-Gärtner HW; Ackermann R
Urologe A; 1998 Nov; 37(6):609-20. PubMed ID: 9887489
[TBL] [Abstract][Full Text] [Related]
15. Testicular seminoma presenting as unilateral gynecomastia.
Kaptanis S; Parvanta L; Beltran L
Breast J; 2014; 20(4):424-6. PubMed ID: 24891095
[No Abstract] [Full Text] [Related]
16. Diffusion-weighted magnetic resonance imaging in the characterization of testicular germ cell neoplasms: Effect of ROI methods on apparent diffusion coefficient values and interobserver variability.
Tsili AC; Ntorkou A; Astrakas L; Xydis V; Tsampalas S; Sofikitis N; Argyropoulou MI
Eur J Radiol; 2017 Apr; 89():1-6. PubMed ID: 28267523
[TBL] [Abstract][Full Text] [Related]
17. Wnt suppressor and stem cell regulator TCF7L1 is a sensitive immunohistochemical marker to differentiate testicular seminoma from non-seminomatous germ cell tumor.
Bu L; Yang Q; McMahon L; Xiao GQ; Li F
Exp Mol Pathol; 2019 Oct; 110():104293. PubMed ID: 31381875
[TBL] [Abstract][Full Text] [Related]
18. Distribution of testicular tumors in Lebanon: a single institution overview.
Assi T; Rassy M; Nassereddine H; Sader-Ghorra C; Abadjian G; Ghosn M; Kattan J
Asian Pac J Cancer Prev; 2015; 16(8):3443-6. PubMed ID: 25921159
[TBL] [Abstract][Full Text] [Related]
19. Semen quality from patients affected by seminomatous and non-seminomatous testicular tumor.
Xavier R; de Carvalho RC; Fraietta R
Int Braz J Urol; 2021; 47(3):495-502. PubMed ID: 32459453
[TBL] [Abstract][Full Text] [Related]
20. Contemporary options and future perspectives: three examples highlighting the challenges in testicular cancer imaging.
Wakileh GA; Ruf C; Heidenreich A; Dieckmann KP; Lisson C; Prasad V; Bolenz C; Zengerling F
World J Urol; 2022 Feb; 40(2):307-315. PubMed ID: 34779884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
